The purpose of this study is to evaluate whether Alexandrite laser treatment is non-inferior to Nd:YAG (neodymium-doped yttrium aluminum garnet) laser treatment of hidradenitis suppurativa (HS).
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
21
Nd:YAG laser applied to one side of the participant's body (e.g. left or right) according to randomization, every 4-6 weeks for 4 consecutive treatments.
Alexandrite laser applied to the contralateral side of the participant's body (e.g. left or right) according to randomization, every 4-6 weeks for 4 consecutive treatments.
HiSCR50
Percentage of patients achieving a 50% reduction in their hidradenitis suppurativa clinical response (HiSCR) score.
Time frame: 6 months
HiSQOL
The Hidradenitis Suppurativa Quality Of Life (HiSQOL) scale, a validated HS quality of life index and is comprised of a 17-item HS-specific HRQOL instrument with a 7-day recall period. Score ranges from 0 to 68, with higher scores indicating more severe impact
Time frame: 6 months
Pain VAS score
Visual analogue score for pain ranging from 0-10 with higher scores indicating worse pain.
Time frame: 6 months
Pruritus numeric rating scale
As measured by a numeric rating scale from 0-10 with higher scores indicating worse itching.
Time frame: 6 months
Days free of disease in last 30 days
The number of days a patient has not had a flare of HS in the past 30 days.
Time frame: 6 months
AN Count
Number of abscesses and nodules on exam
Time frame: 6 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.